Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer
Clinical trial NCT01058785 · COMPLETED
Trial details
- NCT number
- NCT01058785
- Sponsor
- NovaRx Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2005-12-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.